Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2022 Publisher: Essential Pharma Ltd, 7 Egham Business Village, Crabtree Road, Egham, Surrey, TW20 8RB, UK
Verapamil 40mg/5ml Oral Solution.
| Pharmaceutical Form |
|---|
|
Oral Solution. |
Verapamil Hydrochloride 40mg/5ml.
Excipients with known effect:
Propylene glycol (E1520): 500mg/5ml
Liquid Maltitol (E965): 2500mg/5ml
Ethanol: 2.1mg/5ml
Benzoic acid (E210): 5mg/5ml
For the full list of excipients, see Section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Verapamil |
Verapamil inhibits the transmembrane influx of calcium ions into the heart and vascular smooth muscle cell. The myocardial oxygen demand is lowered directly as a result of the effect on the energy consuming metabolic processes of the myocardial cell and indirectly due to a reduction of the afterload. Due to its effect on coronary vascular smooth muscle, verapamil enhances myocardial blood flow, even in post‐stenotic areas, and relieves coronary spasms. These properties contribute to the anti‐ischaemic and antianginal efficacy of verapamil in all types of coronary artery disease. |
| List of Excipients |
|---|
|
Propylene glycol |
Bottle: Amber (Type III) glass.
Closure: HDPE, EPE wadded, tamper evident, child resistant closure.
Pack Size: 150ml.
Essential Pharma Ltd, 7 Egham Business Village, Crabtree Road, Egham, Surrey, TW20 8RB, UK
PL 41871/0021
23 May 2001 / 23 Feb 2007
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
